Reuters logo
BRIEF-Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in China
September 26, 2017 / 8:06 PM / 25 days ago

BRIEF-Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in China

Sept 26 (Reuters) - Amgen Inc

* Amgen and Simcere announce strategic collaboration to co-develop and commercialize biosimilars in China

* Amgen Inc - ‍collaboration includes undisclosed biosimilars in areas of inflammation and oncology​

* Amgen Inc - ‍specific financial terms of agreement were not disclosed​

* Amgen Inc - ‍under terms of deal, amgen will remain responsible for co-development, marketing approval applications and manufacturing of biosimilars​

* Amgen Inc - ‍specific financial terms of agreement were not disclosed.​

* Amgen Inc - ‍biosimilars included in agreement are a part of Amgen’s existing biosimilars portfolio​

* Amgen Inc - ‍Simcere will be responsible for distribution and commercialization of the biosimilars​ in China Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below